Polydorides AD, Harpaz N.  2017.  Serrated lesions in inflammatory bowel disease.. Gastrointest Endosc. 85(2):461.

Laskin BL, Huang G, King E, Geary DF, Licht C, Metlay JP, Furth SL, Kimball T, Mitsnefes M.  2017.  Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium.. Pediatr Nephrol. 32(8):1423-1432.

Nowakowski TJ, Bhaduri A, Pollen AA, Alvarado B, Mostajo-Radji MA, Di Lullo E, Haeussler M, Sandoval-Espinosa C, Liu SJohn, Velmeshev D et al..  2017.  Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex.. Science. 358(6368):1318-1323.

Du W, Seah I, Bougazzoul O, Choi GH, Meeth K, Bosenberg MW, Wakimoto H, Fisher D, Shah K.  2017.  Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.. Proc Natl Acad Sci U S A. 114(30):E6157-E6165.

de Geus SWL, Eskander MF, Kasumova GG, Ng SChau, Kent TS, Mancias JD, Callery MP, Mahadevan A, Tseng JF.  2017.  Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.. Cancer. 123(21):4158-4167.

Lipstein N, Verhoeven-Duif NM, Michelassi FE, Calloway N, van Hasselt PM, Pienkowska K, van Haaften G, van Haelst MM, van Empelen R, Cuppen I et al..  2017.  Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder.. J Clin Invest. 127(3):1005-1018.

Liang H, Zheng Q-L, Fang P, Zhang J, Zhang T, Liu W, Guo M, Robinson CL, Chen S-B, Chen X-P et al..  2017.  Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells.. Sci Rep. 7:40361.

Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, Carrillo M, Martin H, Kasparian S, Syed P et al..  2017.  Targeting type I interferon-mediated activation restores immune function in chronic HIV infection.. J Clin Invest. 127(1):260-268.

Chang AY, Dao T, Gejman RS, Jarvis CA, Scott A, Dubrovsky L, Mathias MD, Korontsvit T, Zakhaleva V, Curcio M et al..  2017.  A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.. J Clin Invest. 127(7):2705-2718.

Lin Y, Haspel RL.  2017.  Transfusion medicine education for non-transfusion medicine physicians: a structured review.. Vox Sang. 112(2):97-104.

Sendoel A, Dunn JG, Rodriguez EH, Naik S, Gomez NC, Hurwitz B, Levorse J, Dill BD, Schramek D, Molina H et al..  2017.  Translation from unconventional 5' start sites drives tumour initiation.. Nature. 541(7638):494-499.

Jay TR, von Saucken VE, Landreth GE.  2017.  TREM2 in Neurodegenerative Diseases.. Mol Neurodegener. 12(1):56.

Röhrig F, Vorlová S, Hoffmann H, Wartenberg M, Escorcia FE, Keller S, Tenspolde M, Weigand I, Gätzner S, Manova K et al..  2017.  VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.. Oncogene. 36(1):1-12.

M Janjua B, Ivasyk I, Greenfield JP.  2017.  Vertebrobasilar Insufficiency Due to Distal Posterior Inferior Cerebellar Artery Compression in Chiari 1.5.. World Neurosurg. 104:1050.e1-1050.e6.

Perez K, Clancy TE, Mancias JD, Rosenthal MH, Wolpin BM.  2017.  When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.. J Clin Oncol. 35(5):485-489.

Liu Y, Pelham-Webb B, Di Giammartino DCampigli, Li J, Kim D, Kita K, Saiz N, Garg V, Doane A, Giannakakou P et al..  2017.  Widespread Mitotic Bookmarking by Histone Marks and Transcription Factors in Pluripotent Stem Cells.. Cell Rep. 19(7):1283-1293.

Zloza A, A Palucka K, Coussens LM, Gotwals PJ, Headley MB, Jaffee EM, Lund AW, Sharpe AH, Sznol M, Wainwright DA et al..  2017.  Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer.. J Immunother Cancer. 5(1):77.

Price EW, Carnazza KE, Carlin SD, Cho A, Edwards KJ, Sevak KK, Glaser JM, de Stanchina E, Janjigian YY, Lewis JS.  2017.  Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection.. J Nucl Med. 58(9):1386-1394.

Ahn D, Peñaloza H, Wang Z, Wickersham M, Parker D, Patel P, Koller A, Chen EI, Bueno SM, Uhlemann A-C et al..  2016.  Acquired resistance to innate immune clearance promotes ST258 pulmonary infection.. JCI Insight. 1(17):e89704.

O'Sullivan TE, Rapp M, Fan X, Weizman O-E, Bhardwaj P, Adams NM, Walzer T, Dannenberg AJ, Sun JC.  2016.  Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance.. Immunity. 45(2):428-41.

Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum N, Alektiar KM, Makker V.  2016.  An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.. Int J Gynecol Cancer. 26(3):497-504.

[Anonymous].  2016.  [Before retirement still quickly into the MVZ - that will not do!].. MMW Fortschr Med. 158(10):37.

Lewis BB, Carter RA, Pamer EG.  2016.  Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates.. Anaerobe. 41:32-36.

Zamolodchikov D, Berk-Rauch HE, Oren DA, Stor DS, Singh PK, Kawasaki M, Aso K, Strickland S, Ahn HJin.  2016.  Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen.. Blood. 128(8):1144-51.

Weber B, Bersch-Ferreira ÂCristine, Torreglosa CRagne, Ross-Fernandes MBeatriz, da Silva JTereza, Galante APolo, Lara Ede Sousa, Costa RPerim, Soares RMarques, Cavalcanti ABiasi et al..  2016.  The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial).. Am Heart J. 171(1):73-81.e1-2.